Whether retatrutide-driven weight loss replicates this in a randomized setting is unknown, but the magnitude of fat loss achieved in Phase 2 makes a favorable signal biologically plausible
Adding another GLP-1 agonist does not increase efficacy
GLP-1 receptor agonists, which activate GLP-1 receptors in the body, have proven to be a breakthrough in restoring that regulation
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: insights from the SUSTAIN 17 trials
There are other FDA-approved oral weight-loss medications available through a prescription, like phentermine, Contrave , and Qsymia
It enables the physician to track the progress of their patient in real-time and modify the treatment plan accordingly